BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33728377)

  • 1. Detailed Clinical and Psychological Phenotype of the X-linked
    Bain JM; Thornburg O; Pan C; Rome-Martin D; Boyle L; Fan X; Devinsky O; Frye R; Hamp S; Keator CG; LaMarca NM; Maddocks ABR; Madruga-Garrido M; Niederhoffer KY; Novara F; Peron A; Poole-Di Salvo E; Salazar R; Skinner SA; Soares G; Goldman S; Chung WK
    Neurol Genet; 2021 Feb; 7(1):e551. PubMed ID: 33728377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males.
    Kreienkamp HJ; Wagner M; Weigand H; McConkie-Rossell A; McDonald M; Keren B; Mignot C; Gauthier J; Soucy JF; Michaud JL; Dumas M; Smith R; Löbel U; Hempel M; Kubisch C; Denecke J; Campeau PM; Bain JM; Lessel D
    Hum Genet; 2022 Feb; 141(2):257-272. PubMed ID: 34907471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in HNRNPH2 on the X Chromosome Are Associated with a Neurodevelopmental Disorder in Females.
    Bain JM; Cho MT; Telegrafi A; Wilson A; Brooks S; Botti C; Gowans G; Autullo LA; Krishnamurthy V; Willing MC; Toler TL; Ben-Zev B; Elpeleg O; Shen Y; Retterer K; Monaghan KG; Chung WK
    Am J Hum Genet; 2016 Sep; 99(3):728-734. PubMed ID: 27545675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense variants in the Arg206 residue of HNRNPH2: Further evidence of causality and expansion of the phenotype.
    Peron A; Novara F; La Briola F; Merati E; Giannusa E; Segalini E; Anniballi G; Vignoli A; Ciccone R; Canevini MP
    Am J Med Genet A; 2020 Apr; 182(4):823-828. PubMed ID: 31943778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine model of hnRNPH2-related neurodevelopmental disorder reveals a mechanism for genetic compensation by Hnrnph1.
    Korff A; Yang X; O'Donovan K; Gonzalez A; Teubner BJ; Nakamura H; Messing J; Yang F; Carisey AF; Wang YD; Patni T; Sheppard H; Zakharenko SS; Chook YM; Taylor JP; Kim HJ
    J Clin Invest; 2023 Jul; 133(14):. PubMed ID: 37463454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for HNRNPH1 being another gene for Bain type syndromic mental retardation.
    Pilch J; Koppolu AA; Walczak A; Murcia Pienkowski VA; Biernacka A; Skiba P; Machnik-Broncel J; Gasperowicz P; Kosińska J; Rydzanicz M; Emich-Widera E; Płoski R
    Clin Genet; 2018 Oct; 94(3-4):381-385. PubMed ID: 29938792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional, quantitative analysis of motor function in females with HNRNPH2-related disorder.
    Salazar R; Beenders S; LaMarca NM; Thornburg O; Rubin-Thompson L; Snow A; Goldman S; Chung WK; Bain JM
    Res Dev Disabil; 2021 Dec; 119():104110. PubMed ID: 34794115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective investigation of FOXP1 syndrome.
    Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD
    Mol Autism; 2017; 8():57. PubMed ID: 29090079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hnRNPH2 gain-of-function mutations reveal therapeutic strategies and a role for RNA granules in neurodevelopmental disorders.
    Kelvington BA; Abel T
    J Clin Invest; 2023 Jul; 133(14):. PubMed ID: 37463443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The different clinical facets of
    Parenti I; Leitão E; Kuechler A; Villard L; Goizet C; Courdier C; Bayat A; Rossi A; Julia S; Bruel AL; Tran Mau-Them F; Nambot S; Lehalle D; Willems M; Lespinasse J; Ghoumid J; Caumes R; Smol T; El Chehadeh S; Schaefer E; Abi-Warde MT; Keren B; Afenjar A; Tabet AC; Levy J; Maruani A; Aledo-Serrano Á; Garming W; Milleret-Pignot C; Chassevent A; Koopmans M; Verbeek NE; Person R; Belles R; Bellus G; Salbert BA; Kaiser FJ; Mazzola L; Convers P; Perrin L; Piton A; Wiegand G; Accogli A; Brancati F; Benfenati F; Chatron N; Lewis-Smith D; Thomas RH; Zara F; Striano P; Lesca G; Depienne C
    Front Cell Dev Biol; 2022; 10():1019715. PubMed ID: 36568968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new Karyopherin-β2 binding PY-NLS epitope of HNRNPH2 is linked to neurodevelopmental disorders.
    Gonzalez A; Kim HJ; Freibaum BD; Joyce Fung HY; Brautigam CA; Taylor JP; Chook YM
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HNRNPH1-related syndromic intellectual disability: Seven additional cases suggestive of a distinct syndromic neurodevelopmental syndrome.
    Reichert SC; Li R; A Turner S; van Jaarsveld RH; Massink MPG; van den Boogaard MH; Del Toro M; Rodríguez-Palmero A; Fourcade S; Schlüter A; Planas-Serra L; Pujol A; Iascone M; Maitz S; Loong L; Stewart H; De Franco E; Ellard S; Frank J; Lewandowski R
    Clin Genet; 2020 Jul; 98(1):91-98. PubMed ID: 32335897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical spectrum of KIAA2022/NEXMIF pathogenic variants in males and females: Report of three patients from Indian kindred with a review of published patients.
    Panda PK; Sharawat IK; Joshi K; Dawman L; Bolia R
    Brain Dev; 2020 Oct; 42(9):646-654. PubMed ID: 32600841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo ARHGEF9 missense variants associated with neurodevelopmental disorder in females: expanding the genotypic and phenotypic spectrum of ARHGEF9 disease in females.
    Scala M; Zonneveld-Huijssoon E; Brienza M; Mecarelli O; van der Hout AH; Zambrelli E; Turner K; Zara F; Peron A; Vignoli A; Striano P
    Neurogenetics; 2021 Mar; 22(1):87-94. PubMed ID: 32939676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
    Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
    Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.